4/A//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4/A
Accession 0001209191-15-052655
CIK 0001373707operating
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 1:19 PM ET
Size
5.9 KB
Accession
0001209191-15-052655
Insider Transaction Report
Form 4/AAmended
Transactions
- Award
Stock option (right to buy)
2015-06-10+0→ 0 totalExercise: $42.26Exp: 2025-06-09→ Common Stock (0 underlying)
Footnotes (1)
- [F1]Vests in equal quarterly installments over a one-year period measured from the date of grant.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 1:19 PM ET
- Size
- 5.9 KB